Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB/II of CPX-351 as Maintenance Therapy in AML Patients Ineligible for Bone Marrow Transplantation

NCT04990102 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT04990102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04990102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB/II of CPX-351 as Maintenance Therapy in AML Patients Ineligible for Bone Marrow Transplantation
Lead sponsor
Georgetown University
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 22, 2023
Completion date
December 31, 2026
Enrollment
24 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml) in remission